Henlez
Develops enzyme-powered topical products for improved management of skin conditions
Calluna Pharma
formerly known as Arxx Therapeutics, develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis
Dianox
Developing diagnostic self-tests
